Love your work Torpy, thanks.
Yes I have questioned why the heck would the Sydney dudes (ok researchers and team) even bother with pill format of PPS when they know the bioavailability and that it is patented and supply would be an issue in a commercial sense later on granted our IP, our relationship and contracts in place with Bene.
Simple answer could really be that they are just researching it, under that umbrella they are even allowed to be able to source from Bene without contravening any patents etc. Could be just a simple perusal of research?
Agreed, always good when an independent body condones your work. This is one of the reasons why I love to get multiple sources of confirmation if possible and how important it is to get our work/studies peer reviewed and by the more reputable peer review publishers, might equate to more time and effort and perhaps cost, but worth it when we hit the world stage.
My views
- Forums
- ASX - By Stock
- PAR
- research reports and media
research reports and media, page-2026
-
- There are more pages in this discussion • 2,370 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.0¢ |
Change
-0.005(2.13%) |
Mkt cap ! $80.45M |
Open | High | Low | Value | Volume |
24.0¢ | 25.5¢ | 23.0¢ | $169.7K | 718.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 152403 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 9990 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 152403 | 0.225 |
4 | 94545 | 0.220 |
1 | 10000 | 0.215 |
6 | 124516 | 0.210 |
3 | 124000 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 9990 | 1 |
0.240 | 10000 | 1 |
0.245 | 37318 | 1 |
0.250 | 100000 | 1 |
0.255 | 3356 | 1 |
Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |